The new approach will ensure that high-impact devices, diagnostics and digital tools recommended by NICE, that meet the most urgent needs, are nationally reimbursed and made available across the NHS - ...

Leadless cardiac pacemaker implantation for bradyarrhythmias Interventional procedure consultation Interventional procedures guidance 23 July 2025 Low energy contact X-ray brachytherapy for rectal ...

continuing medical education (CME) resources. Buyers must follow normal public sector procurement rules and local financial regulations. NHS buyers can seek exception approval to use our framework by ...

Evidence-based recommendations on sparsentan (Filspari) for treating primary immunoglobulin A (IgA) nephropathy in adults.. Last reviewed: 25 June 2025 Next review: This guidance will be reviewed if ...

In this guest blog, Dale Greenwood, mental health lead for East London NHS Foundation Trust, shares how his trust implemented ...

The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs ...

Evidence-based recommendations on nivolumab (Opdivo) plus ipilimumab (Yervoy) for untreated unresectable or metastatic colorectal cancer with high microsatellite instability in adults.. Last reviewed: ...

Evidence-based recommendations on dostarlimab (Jemperli) with platinum-based chemotherapy for primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair ...

Guidance programme Guidance programme Antimicrobial prescribing guidelines (20) Cancer service guidelines (8) Clinical guidelines (226) COVID-19 rapid guidelines (3) Diagnostics guidance (50) Health ...

Thousands of people a year could benefit from new twice-a-day tablet for advanced breast cancer. We've published final draft guidance recommending capivasertib with fulvestrant, which means the ...

The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also ...

Groundbreaking one-off gene therapy approved for severe sickle cell disease. People in England with severe sickle cell disease will be among the first to receive treatment using revolutionary CRISPR ...